VAXX Stock Performance, Insider Transaction and News

VAXX - Vaxxinity, Inc.

Market Cap	317.62M	P/E	-	EPS this Y	23.30%	Ern Qtrly Grth	-
Income	-56.93M	Forward P/E	-3.64	EPS next Y	17.40%	50D Avg Chg	8.00%
Sales	-	PEG	0.00	EPS past 5Y	-	200D Avg Chg	16.00%
Dividend	N/A	Price/Book	6.86	EPS next 5Y	-51.60%	52W High Chg	-44.00%
Recommedations	1.00	Quick Ratio	1.76	Shares Outstanding	112.91M	52W Low Chg	102.00%
Insider Own	50.91%	ROA	-48.34%	Shares Float	55.31M	Beta	2.80
Inst Own	10.86%	ROE	-150.65%	Shares Shorted/Prior	4.22M/3.85M	Price	2.51
Gross Margin	-	Profit Margin	-	Avg. Volume	229,066	Target Price	15.00
Oper. Margin	-	Earnings Date	Aug 7	Volume	61,914	Change	-4.20%

Healthcare | Biotechnology | United States

About Vaxxinity, Inc.

Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States. Its product pipeline comprises UB-311, which is in phase 2 clinical trial that targets toxic forms of aggregated amyloid-b in the brain to fight alzheimer's disease; UB-312, which is in phase 1 clinical trial that targets toxic forms of aggregated a-synuclein in the brain to fight parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy; and VXX-301, which is in preclinical trial, an anti-tau product candidate for various neurodegenerative conditions, including alzheimer's disease, traumatic brain injury, and chronic traumatic encephalopathy. It also develops VXX-401, which is phase 1 clinical trial that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; UB-313 that targets calcitonin gene-related peptide to fight migraines; and UB-612, neutralizes the SARS-CoV-2 virus and is in phase 3 clinical trial. The company was incorporated in 2021 and is headquartered in Merritt Island, Florida.

Vaxxinity, Inc. News

04/19/24	Vaxxinity Issues Shareholder Letter
04/19/24	Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
03/28/24	Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
03/27/24	Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates
03/07/24	Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024
02/15/24	Vaxxinity’s Heart Health Innovation to Reduce LDL Cholesterol Levels
02/15/24	Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published
02/13/24	Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024
01/30/24	Vaxxinity, UF Join Forces Against Neurodegenerative Diseases
01/30/24	Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida
01/19/24	Vaxxinity & UCF to Collaborate on Space Medicine Research
08:00 AM	Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida
01/03/24	Vaxxinity to Present at the 2024 J.P. Morgan Healthcare Conference
12/12/23	The Zacks Analyst Blog Highlights Biogen, Prothena, AC Immune's and Vaxxinity
11/20/23	FOCUS-Researchers return to Alzheimer's vaccines, buoyed by recent drug success
11/13/23	Vaxxinity to Present at Upcoming November Medical and Investor Conferences
11/08/23	Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update
10/10/23	Private companies invested in Vaxxinity, Inc. (NASDAQ:VAXX) copped the brunt of last week's US$41m market cap decline
09/07/23	Down -22.18% in 4 Weeks, Here's Why You Should You Buy the Dip in Vaxxinity, Inc. (VAXX)
08/29/23	Vaxxinity to Present at Upcoming Investor Conferences in September

VAXX Chatroom

MNNs12 Posted - 1 day ago

$VAXX 🤡🤡🤡🤡

Russ_E_Biker Posted - 2 days ago

$VAXX Get your shares NOW while they are still available at this bargain basement price! Company has a great pipeline and just one positive PR and it doubles, triples or more.

kingdawit Posted - 4 days ago

$VAXX it will go up $0.60 just wait

intratio Posted - 6 days ago

Vaxxinity, Inc. The trained A.I concludes that the value of this company will quickly deteriorate in the near future with a clear pessimistic long-term perspective $VAXX

Calida760 Posted - 1 week ago

$VAXX april 23 I posted vaxx will crash below .10. .05 now will bottom. 01 on otc

lecorb Posted - 1 week ago

$AFIB $VAXX to OTC.PK

beppels Posted - 1 week ago

$IVP from my wl today, 3.8 to 5.2! $nbse, watch it, delisting monday, all recent delisting plays like $vaxx or $afib had at least one final 50 percent run before delisting and $nbse has the smallest mc and float of them all, it s today or never!

Stockguru222 Posted - 1 week ago

$VAXX

Badstonks561 Posted - 1 week ago

$VAXX dead horse

Kblek Posted - 1 week ago

$VAXX will fly today 👀

GODVESSEL Posted - 1 week ago

$VAXX NASDAQ gave until August 7 to reach the minimum one dollar equity ; since they’re voluntarily delisting they will continue to trade on the OTC

GODVESSEL Posted - 1 week ago

$VAXX

beppels Posted - 1 week ago

$NBSE at 0.33 $nbse has a mc of 1.2 mln. most delisting stocks go into delisting with mc s between 2 and 5 mln. look at $vaxx, delisting in 3 days, mc still 17.5 mln. imo $nbse has a good chance for a final spike before the delisting next monday. $ffie and $zvsa hot too today!

Spacetaco Posted - 1 week ago

$VAXX

Gaphunters Posted - 1 week ago

$VAXX I count all my penny’s!

savannahs Posted - 1 week ago

$VAXX easy BACK TO $4. Company's awesome 👌 earnings. Great drug breakthrough development waiting for final approval, employees grabbing more shares. Last month, 🌎 drug presentations in Colorado, late Friday 05/3/2024 filing in Continuation Of being on "NOTICEOF EFFECTIVENESS". NO MORE VOLUNTRY DELISTING!. YES! This stock is about to go up north 🚀 🚀 🚀 🚀 🚀.

savannahs Posted - 1 week ago

$VAXX News flash "NOTICE OF EFFECTIVE" has been filed. BULLISH AS F**K!

suckitbaby Posted - 1 week ago

$VAXX 🚀

intratio Posted - 1 week ago

$VAXX https://www.intratio.com/stock-forecast/VAXX Vaxxinity, Inc. The trained model reaches the conclusion this stock s price will fall sharply in the short-term and is poised to drop further in the coming weeks

intratio Posted - 1 week ago

$VAXX Vaxxinity, Inc. Our statistical model has forecasted the price action of this stock has an extremely bleak prognosis for the near future and will continue to have a very poor trend over the next months

Game_Day Posted - 2 weeks ago

Over 14 days no loss 🏆 great weekend everyone 🍻 Options $FTNT C ⭐️ 9% $DLTR P ⭐️ 3% hold Stocks $VAXX ⭐️ 13% $AQST ⭐️ 2% hold

momoneyinstl Posted - 2 weeks ago

$VAXX get in! This will run 500% up to Wednesday, I’ve seen it a hundred times

Fennavelli Posted - 2 weeks ago

$MI and $VAXX for some after hours friday pleasure

Fennavelli Posted - 2 weeks ago

$VAXX looking beautiful

Mattusmc18 Posted - 2 weeks ago

$VAXX follow me!!

topstockalerts Posted - 2 weeks ago

$VAXX curling up

Saibhagat Posted - 2 weeks ago

$VAXX give me .17

GODVESSEL Posted - 2 weeks ago

Into $VAXX , though $CSSE seeming like it may want to make the leap to fill at $1 [ $GETR : not even at $20 Million capital drawn (after prior valuation) and still $30 Million or 150% upside on finance agreement , alone

MicsMugz Posted - 2 weeks ago

$JAGX $SGBX $VAXX $BRSH $BENF Let's see Mr Scott haven't been following your plays recently I'm gonna take you word on this day Let's go

DavidScott Posted - 2 weeks ago

$JAGX $SGBX $VAXX $BRSH $BENF = Powerhour Watch 🔥📈👀

Analyst Ratings

Baird	Outperform	Sep 8, 23
Evercore ISI Group	In-Line	Apr 27, 22
Jefferies	Buy	Dec 7, 21
B of A Securities	Buy	Dec 6, 21

Insider Trades	Relationship	Date	Transactions	Cost($)	#Shares	Value($)	#Share Own	SEC Form 4
Prime Movers Lab Fund I LP	10% Owner 10% Owner	Sep 06	Sell	1.78	96,936	172,546	3,594,122	09/08/23
Diamandis Peter	Director Director	Apr 26	Option	0.89	475,537	423,228	906,141	05/02/23
Prime Movers Lab Fund I LP	10% Owner 10% Owner	Jan 23	Sell	3.35	500,692	1,677,318	8,764,372	01/25/23
Prime Movers Lab Fund I LP	10% Owner 10% Owner	Dec 01	Sell	2.77	348,548	965,478	9,169,589	12/05/22
Prime Movers Lab Fund I LP	10% Owner 10% Owner	Sep 06	Sell	2.4	37,358	89,659	9,451,674	09/08/22
Guirakhoo Farshad	(Former) Chief Scien.. (Former) Chief Scientific Off.	Jan 13	Option	0.57	58,645	33,428	68,645	08/29/22
Prime Movers Lab Fund I LP	10% Owner 10% Owner	Aug 23	Sell	2.39	207,680	496,355	9,476,917	08/25/22
Diamandis Peter	Director Director	Nov 18	Sell	13	248	3,224	90,499	06/23/22
Reese Lou	Executive Chairman Executive Chairman	Jun 16	Buy	1.9929	100,000	199,290	51,737,344	06/21/22
Hu Mei Mei	See Remarks See Remarks	Jun 16	Buy	1.9929	100,000	199,290	51,737,344	06/21/22
UNITED BIOMEDICAL INC	10% Owner 10% Owner	Jun 16	Buy	1.9929	100,000	199,290	51,737,344	06/21/22
Prime Movers Lab Fund I LP	10% Owner 10% Owner	Jun 10	Sell	2.61	179,000	467,190	9,617,245	06/14/22
UNITED BIOMEDICAL INC	10% Owner 10% Owner	Jun 08	Buy	2.84	20,978	59,578	51,637,344	06/10/22
Hu Mei Mei	See Remarks See Remarks	Jun 08	Buy	2.84	20,978	59,578	51,637,344	06/10/22
Reese Lou	Executive Chairman Executive Chairman	Jun 08	Buy	2.84	20,978	59,578	51,637,344	06/10/22
Guirakhoo Farshad	Chief Scientific Off.. Chief Scientific Officer	May 03	Option	0.57	10,000	5,700	10,000	05/05/22
UNITED BIOMEDICAL INC	10% Owner 10% Owner	Apr 26	Buy	3.52	22,912	80,650	51,616,366	04/28/22
Reese Lou	Executive Chairman Executive Chairman	Apr 26	Buy	3.52	22,912	80,650	51,616,366	04/28/22
Hu Mei Mei	See Remarks See Remarks	Apr 26	Buy	3.52	22,912	80,650	51,616,366	04/28/22
Hu Mei Mei	See Remarks See Remarks	Apr 25	Buy	3.3681	8,038	27,073	51,593,454	04/27/22
Reese Lou	Executive Chairman Executive Chairman	Apr 25	Buy	3.3681	8,038	27,073	51,593,454	04/27/22
UNITED BIOMEDICAL INC	10% Owner 10% Owner	Apr 25	Buy	3.3681	8,038	27,073	5,193,454	04/27/22
Diamandis Peter	Director Director	Jan 24	Option	4.1192	652,764	2,688,865	729,687	01/26/22
Chui James	Director Director	Dec 31	Buy	5.48	6,000	32,880	14,000	01/06/22
Reese Lou	Executive Chairman Executive Chairman	Nov 12	Buy	13.82	17,500	241,850	17,500	11/15/21
Hu Mei Mei	See Remarks See Remarks	Nov 12	Buy	13.82	17,500	241,850	17,500	11/15/21